Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Fusen Pharmaceutical Co., Ltd. ( (HK:1652) ).
Fusen Pharmaceutical Co., Ltd. has announced a discloseable transaction involving the sale of its entire equity interests in Henan Fusen Intelligent Energy Conservation Technology Company Limited. The transaction is valued at RMB73.0 million and involves a conditional agreement with a purchaser owned by state and local government authorities in China. This strategic move is part of Fusen Pharmaceutical’s efforts to streamline its operations and focus on its core business areas. The disposal is subject to certain conditions and regulatory requirements, and stakeholders are advised to exercise caution.
The most recent analyst rating on (HK:1652) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Fusen Pharmaceutical Co., Ltd. stock, see the HK:1652 Stock Forecast page.
More about Fusen Pharmaceutical Co., Ltd.
Average Trading Volume: 1,960,742
Technical Sentiment Signal: Buy
Current Market Cap: HK$713.2M
See more insights into 1652 stock on TipRanks’ Stock Analysis page.